Viatris, Inc. (VTRS)
11.09
+0.16
(+1.46%)
USD |
NASDAQ |
Dec 08, 16:00
11.17
+0.08
(+0.72%)
Pre-Market: 08:30
Viatris EPS Diluted (Quarterly): -0.1101 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pfizer Inc. | 0.6197 |
| Amgen, Inc. | 5.934 |
| BioCryst Pharmaceuticals, Inc. | 0.0587 |
| QuidelOrtho Corp. | -10.78 |
| Indivior PLC | 0.3256 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -128.20M |
| Revenue (Quarterly) | 3.762B |
| Total Expenses (Quarterly) | 3.890B |
| Enterprise Value | 26.39B |
| Gross Profit Margin (Quarterly) | 36.87% |
| Profit Margin (Quarterly) | -3.41% |
| Earnings Yield | -27.93% |
| Operating Earnings Yield | 7.71% |
| Normalized Earnings Yield | -10.12 |